A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NERD / non-erosive reflux disease

[Related PubMed/MEDLINE]
Total Number of Papers: 460
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NERD  (>> Co-occurring Abbreviation)
Long Form:   non-erosive reflux disease
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study. CBT, DCI, FD, HRIM, PPI
2020 Efficacy of a new nutraceutical formulation (CHETOGERD) in patients with nonerosive reflux disease (NERD): a prospective observational study. oro, PPIs, RDQ
2020 Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease. GERD, PPIs, RE, VPZ
2020 Measurement of Esophageal Nocturnal Baseline Impedance: A Simplified Method. FH, GERD, MII-pH, MNBI
2020 Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease. GERD
2020 Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole. EE, GERD
2020 Polysaccharide from Gracilaria caudata protects the human esophageal mucosal barrier: A differential topical effect and structural dependence. SP-Gc, TEER
2020 Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms. EES, MNBI, PPI, PSPW, RH
2020 Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders. EES, GERD, GerdQ, HC, SPC
10  2020 Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up. LES, PPI
11  2020 The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease. MII-pH, PPI, SAP, SI, VPZ
12  2020 Untangling Non-erosive Reflux Disease From Functional Heartburn. ---
13  2019 A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. BMI, CIs, ESCC, GERD, ORs, RE
14  2019 A Randomized Placebo-Controlled N-of-1 Trial: The Effect of Proton Pump Inhibitor in the Management of Gastroesophageal Reflux Disease. GERD, GerdQ, PPI
15  2019 Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease. GERD, HRM, MII-pH, OTE, PPIs
16  2019 Cashew gum, a biopolymer, topically protects oesophageal mucosa in non erosive reflux disease: A promising translational study. CG, TER
17  2019 Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease. BI, ENRD, FH, MBI, MNBI, PPI
18  2019 Detection of minimal mucosal esophageal lesions in non-erosive gastroesophageal reflux disease using optical enhancement plus optical magnification. GERD, IPCLs, MMEL
19  2019 Diagnostic performance of the endoscopic pressure study integrated system (EPSIS): a novel diagnostic tool for gastroesophageal reflux disease. CI, EPSIS, GERD, IGP, IGP, OR
20  2019 Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. PPIs
21  2019 Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study. ---
22  2019 Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study. ---
23  2019 Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non-erosive reflux disease patients. FH, HV
24  2019 Gender-specific Effect of Micronutrient on Non-erosive Reflux Disease and Erosive Esophagitis. CI, OR
25  2019 High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients. AET, GERD, HRM, HVs, SAP
26  2019 Influence of the pH Value of Refluxate and Proximal Extent on Heartburn Perception in Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease. PPI
27  2019 Role of Esophageal Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Discriminating Chinese Patients With Heartburn. EE, FH, MNBI, PSPW, RH
28  2019 The effect of Heweijiangni-decoction on esophageal morphology in a rat model of OVA-induced visceral hypersensitivity followed by acid exposure. DIS, HWJND, OVA
29  2019 Visceral fat thickness of erosive and non-erosive reflux disease subjects in Indonesia's tertiary referral hospital. ERD, GERD, GerdQ, LA classifications
30  2018 Abnormal Gastroesophageal Flap Valve Is Associated With High Gastresophageal Reflux Disease Questionnaire Score and the Severity of Gastroesophageal Reflux Disease in Vietnamese Patients With Upper Gastrointestinal Symptoms. GEFV, GerdQ, RE
31  2018 Antireflux surgery is equally beneficial in nonerosive and erosive gastroesophageal reflux disease. ERD, GERD
32  2018 Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study. AEE, ERD, GERD
33  2018 Comparative Study of Alginate and Omeprazole in Symptomatic Treatment of Non-erosive Gastroesophageal Reflux Disease. GERD
34  2018 Comparison of Tight Junction Protein-Related Gene mRNA Expression Levels between Male and Female Gastroesophageal Reflux Disease Patients. CLDN1, CLDN4, ERD, GERD, NK1R, OCLN, ZO
35  2018 Differences in salivary secretory function between patients with erosive esophagitis and those with nonerosive reflux disease. EE, HS
36  2018 Effect of high-fat, standard, and functional food meals on esophageal and gastric pH in patients with gastroesophageal reflux disease and healthy subjects. EAE, GERD, IQR, RE
37  2018 Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial. GERD
38  2018 Efficacy and Safety of Traditional Chinese Medicine on Nonerosive Reflux Disease: A Meta-Analysis of Randomized Controlled Trials. PPIs, RCTs, TCM
39  2018 Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis. BI, HCs, SSc
40  2018 Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment. AUC, DIS, EE, GERD, PPI
41  2018 Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients. ---
42  2018 Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease - PAN-STAR. ERD, GERD
43  2018 Mucosal Impedance Measurements Differentiate Pediatric Patients With Active Versus Inactive Eosinophilic Esophagitis. EoE
44  2018 On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis. CI, EE, GERD, OR, PPIs, RCTs
45  2018 Pathogenesis of Potassium-Competitive Acid Blocker-Resistant Non-Erosive Reflux Disease. P-CAB, SI
46  2018 Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease. ENT, GERD, IBS, PPI
47  2018 Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia. AET, DCI, GERD, HRM, PPI
48  2018 Role of TRPV1 receptor in inflammation and impairment of esophageal mucosal integrity in a murine model of nonerosive reflux disease. KC, MPO, TEER, TRPV1
49  2018 Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders. ---
50  2018 The overlap syndrome of urticaria and gastroesophageal reflux disease. BE, CSU, EBC, GERD, GICs, Tot-IgE, UAS
51  2018 The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study. EGJ-CI, FH, RH
52  2018 Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn. AET, FH, HE
53  2018 [Analysis of clinical data, esophageal motility and reflux characteristics in patients with non-erosive reflux disease(NERD) and reflux esophagitis(RE)]. RE
54  2017 A baseline impedance analysis in neurologically impaired children: A potent parameter for estimating the condition of the esophageal mucosa. BI, ERD, GERD, NI
55  2017 A novel murine model of esophageal nonerosive reflux disease: from inflammation to impairment in mucosal integrity. KC, MPO, TEER
56  2017 Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn. AET, FH, HRE, MII-pH
57  2017 Associations among gastroesophageal reflux disease, psychological stress, and sleep disturbances in Japanese adults. a-ERD, AIS, GERD, HADS, s-ERD
58  2017 Central Obesity as a Risk Factor for Non-Erosive Reflux Disease. OR
59  2017 Comparison of oesophageal function tests between Chinese non-erosive reflux disease and reflux hypersensitivity patients. HRiM, RH
60  2017 Complexity and diversity of gastroesophageal reflux disease phenotypes. GERD
61  2017 Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects. CI, OR
62  2017 Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia. FD, GERD, GOS, P-CAB, RE, VPZ
63  2017 Epidemiology and natural history of gastroesophageal reflux disease. ERD, GERD
64  2017 Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease. CAAG, FH, MNBI, PSPW
65  2017 Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial. MII-EM, PPI, RKT, UMIN
66  2017 Esophagogastric junction contractile integral and morphology: Two high-resolution manometry metrics of the anti-reflux barrier. CD, CI, EGJ, ERD, GERD, LES
67  2017 Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease. EE, TEER, TRPV1
68  2017 Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan. GSRS, HADS, IBS, PPI, QOL
69  2017 Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease? GERD, MII-pH
70  2017 Medicinal Plants for Management of Gastroesophageal Reflux Disease: A Review of Animal and Human Studies. GERD, PPIs
71  2017 Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection. EoE, PPI, SI
72  2017 Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe. GERD, PPI
73  2017 Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. HRQL, PPIs
74  2017 Relationship Between Salivary Pepsin Concentration and Esophageal Mucosal Integrity in Patients With Gastroesophageal Reflux Disease. FH, HO, IS, MII-pH
75  2017 Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease. BE, CGRP, ERD, IQR
76  2017 Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease. MII-pH, PPIs, VAS
77  2017 The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring. FH, GERD, HRE, MNBI, PPI, PSPW, ROC, RRE
78  2017 The natural history of gastro-esophageal reflux disease: a comprehensive review. ERD, GERD
79  2017 The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease. DDR, GERD, MR, PPI
80  2017 [Clinical trial of gastroesophageal reflux disease with the disharmony between liver and stomach syndrome treated with acupuncture regulating qi based on the compatibility of the five meridians]. RE
81  2016 Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease. MNBI, PSPW, SAP, SI
82  2016 Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India. GERD, MICs, NUD
83  2016 Association between Pattern of Gastritis and Gastroesophageal Reflux Disease in Patients with Helicobacter Pylori Infection. GERD, H. pylori
84  2016 Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study. AFI, FH, PPI, WLI
85  2016 Belching during gastroscopy and its association with gastroesophageal reflux disease. EGD, GERD
86  2016 Between GERD and NERD: the relevance of weakly acidic reflux. GERD
87  2016 Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn. FH
88  2016 Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. ---
89  2016 High-definition endoscopy with iScan and Lugol's solution for the detection of inflammation in patients with nonerosive reflux disease: histologic evaluation in comparison with a control group. ERD, HD
90  2016 Identifying Minimal Changes in Nonerosive Reflux Disease: Is the Pay Worth the Labor? ---
91  2016 Impact of body weight on clinical symptoms and endoscopic changes in patients with gastroesophageal reflux disease. BE, BMI, EE, GERD
92  2016 Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms. ERD, GDNF, GERD, IL, LA, NGF, PAR2, qPCR, TRPV1
93  2016 Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate. ERD, HVs, IBP, TLESRs, TSPG
94  2016 Motility characteristics in the transition zone in Gastroesophageal Reflux Disease (GORD) patients. BT, FH, GORD, HO, HRIM, MII-pH, RE, TZ
95  2016 Non-erosive reflux disease (NERD). ---
96  2016 Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry. BMI, EGJ, FD, GERD, HRM, MII-pH, PPI
97  2016 Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease. CI
98  2016 Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors. BILs, FH, GERD, RE, RGERD
99  2016 Sex and Gender Differences in Gastroesophageal Reflux Disease. BE, EAC, GERD
100  2016 The Effect of Zinc Supplementationon the Symptoms of Gastroesophageal Reflux Disease; a Randomized Clinical Trial. ERD, GERD, GI, IRCT, RDQ